GHRP-6 Acetate | Research Use Only

What it is

GHRP-6, or growth hormone-releasing peptide-6, is a synthetic growth hormone secretagogue studied in research settings for its interaction with the growth hormone secretagogue receptor pathway. Reviews of the GHRP class describe GHRP-6 as one of the earliest and most extensively studied hexapeptide secretagogues used in endocrine and receptor-signaling research.

Origins and design rationale

GHRP-6 was developed as part of the synthetic growth hormone-releasing peptide family to investigate non-GHRH pathways of growth hormone release. Academic reviews describe the GHRPs as synthetic peptides created to stimulate growth hormone secretion through distinct receptor mechanisms, with GHRP-6 serving as an early template for later peptide and non-peptide secretagogues.

Molecular profile

GHRP-6 is commonly described as a synthetic hexapeptide. PubChem lists GHRP-6 with the molecular formula C46H56N12O6 and identifies it as a growth hormone-releasing peptide compound used in biochemical research contexts.

Scientific overview

In simplified terms, GHRP-6 is used in research to study growth hormone secretagogue receptor signaling, endocrine response patterns, and related neuroendocrine pathways. PubChem identifies the human growth hormone secretagogue receptor type 1 as a receptor that binds ghrelin as well as other growth hormone releasing peptides such as GHRP-6, supporting its use in receptor and signaling studies.

What researchers study with GHRP-6 Acetate

Key research focus areas often include
• Growth hormone secretagogue receptor signaling
• Endocrine and neuroendocrine response modeling
• Comparative studies of GHRP-6 versus other synthetic secretagogues
• Cell and receptor pathway studies involving ghrelin-related signaling

Regulatory and compliance notice

Research Use Only. Not for human or veterinary use. This description is provided for scientific context and must not be used to market GHRP-6 Acetate for diagnosis, cure, mitigation, treatment, or prevention of disease.

Citations and references

PubChem compound entry for GHRP-6, includes molecular formula and compound information.

Ghigo et al. Growth hormone-releasing peptides, review describing GHRP-6 as the first hexapeptide extensively studied in humans and summarizing GHRP receptor activity.

Camanni et al. Growth hormone-releasing peptides and their analogs, review covering the synthetic GHRP family and development rationale for GHRP-6 and related compounds.

PubChem entry for human growth hormone secretagogue receptor type 1, notes receptor binding to ghrelin and other growth hormone releasing peptides such as GHRP-6.

Frago et al. Growth hormone-releasing peptide-6 increases insulin-like growth factor-I mRNA levels and activates Akt in RCA-6 cells, study describing cellular signaling effects of GHRP-6 in a research model.